Novartis AG Total Current Liabilities 2010-2024 | NVS

Novartis AG total current liabilities for the quarter ending September 30, 2024 were $28.132B, a 41.87% decline year-over-year.

  • Novartis AG total current liabilities for 2023 were $26.39B, a 7.91% decline from 2022.
  • Novartis AG total current liabilities for 2022 were $28.656B, a 5.14% decline from 2021.
  • Novartis AG total current liabilities for 2021 were $30.208B, a 8.62% decline from 2020.

Novartis AG Total Current Liabilities 2010-2024 | NVS

  • Novartis AG total current liabilities for 2023 were $26.39B, a 7.91% decline from 2022.
  • Novartis AG total current liabilities for 2022 were $28.656B, a 5.14% decline from 2021.
  • Novartis AG total current liabilities for 2021 were $30.208B, a 8.62% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B